Aptorum Group Limited (NASDAQ:APM) Short Interest Update

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 184,800 shares, an increase of 1,564.9% from the December 31st total of 11,100 shares. Approximately 4.7% of the shares of the stock are short sold. Based on an average daily volume of 2,190,000 shares, the short-interest ratio is presently 0.1 days.

Aptorum Group Price Performance

Shares of APM stock traded down $0.15 during trading hours on Tuesday, reaching $1.10. 213,151 shares of the stock were exchanged, compared to its average volume of 1,177,477. Aptorum Group has a 12-month low of $0.46 and a 12-month high of $17.49. The company’s 50-day moving average price is $1.07 and its 200-day moving average price is $1.98.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.